Literature DB >> 14128

Control of 3-hydroxy-3-methylglutaryl coenzyme A reductase by endogenously synthesized sterols in vitro and in vivo.

P A Edwards, G Popják, A M Fogelman, J Edmond.   

Abstract

Isolated rat hepatocytes converted mevalonolactone into sterol intermediates and fatty acids 6- to 8-fold faster than mevalonate salt at concentrations less than 6 X 10(-4) M. Incubation of hepatocytes for 3 h normally results in induction of 3-hydroxy-3-methylglutaryl-CoA reductase. This increase in enzyme activity was inhibited by mevalonolactone and by mevalonate salt; at each concentration between 6 X 10(-4) M and 6 X 10(-8) M the lactone was a more effective inhibitor than the salt. The increase in enzyme activity was completely prevented by 6 X 10(-4) M lactone, and at this concentration the cells synthesized from the lactone an amount of sterol per hour which approximated that leavingthe cells in the same period. Administration of mevalonolactone to intact rats resulted in a dose-dependent inhibition of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity. At the highest dose (400 mg of (RS)-mevalonolactone/200 g of rat) enzyme activities declined 85% within 45 min and were still suppressed below normals after 28 h. Mevalonolactone treatment resulted in increases in liver cholesterol content and in the cholesterol ester concentration of liver microsomes. The results demonstrate that the activity of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase can be controlled by the rate of endogenous sterol synthesis both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14128

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Relationship between activity of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and secretion of very-low-density-lipoprotein cholesterol by the isolated perfused liver and in the intact rat.

Authors:  E H Goh; M Heimberg
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

Review 2.  Cholesterol metabolism in man.

Authors:  S M Grundy
Journal:  West J Med       Date:  1978-01

3.  A discoordinate increase in the cellular amount of 3-hydroxy-3-methylglutaryl-CoA reductase results in the loss of rate-limiting control over cholesterogenesis in a tumour cell-free system.

Authors:  N I Azrolan; P S Coleman
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

4.  Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.

Authors:  T Kita; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

5.  Perinatal development of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in rat lung, liver and brain.

Authors:  G C Ness; J P Miller; M H Moffler; L S Woods; H B Harris
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

6.  Independent regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and chylomicron remnant receptor activities in rat liver.

Authors:  D P Wade; A K Soutar; G F Gibbons
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

7.  The role of substrate supply in the regulation of cholesterol biosynthesis in rat hepatocytes.

Authors:  C R Pullinger; G F Gibbons
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

8.  (R)-mevalonate excretion in human and rat urines.

Authors:  R R Kopito; H Brunengraber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  In vivo regulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase: enzyme phosphorylation as an early regulatory response after intragastric administration of mevalonolactone.

Authors:  R E Arebalo; J E Hardgrave; B J Noland; T J Scallen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Dolichol biosynthesis in human malignant cells.

Authors:  A Henry; P W Stacpoole; C M Allen
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.